CompoAtlas

Artemisia vulgaris Extrakt

Food supplement declared in France, declaration No 2021-11-18, decision dated 1 November 2021

Artemisia vulgaris Extrakt (Vegavero) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Artemisia vulgaris 600 mg per day. 1 rule of use applies to its ingredients (limits and warnings).

Brand
Vegavero
Food business operator placing the product on the market
Vanatari International GmbH
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
1
Directions for use
Prenez 1 gélule par jour avec suffisamment de liquide pendant le repas.

Declaration 179849, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Artemisia vulgaris L.Parties aériennesExtrait sec hydroalcoolique600 mg

Additives

E464

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Les compléments alimentaires ne se substituent pas à une alimentation saine et variée ni à un exercice physique régulier.Ne pas dépasser la dose journalière indiquée. Tenir hors de portée des enfants. Conserver dans un endroit sombre, frais et sec.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Artemisia vulgaris L.
    Read the warning, when it applies and the studies cited

    MUGWORT - ARTEMISIA VULGARIS

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Brinker 2010; Blumenthal et al. 1998; Williamson et al. 1988).

    Sources cited by Health Canada (3)
    • Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C, Rister R, editors. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin (TX): American Botanical Council; 1998.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Williamson EM, Evans FJ, Wren RC. Potter's New Cyclopaedia of Botanical Drugs and Preparations. Saffron Walden (UK): C.W. Daniel Company Limited; 1988.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010; Wichtl 2004; Hoffmann 2003).

    Sources cited by Health Canada (3)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Hoffmann D. Medical Herbalism. Rochester (VT): Healing Arts Press; 2003.
    • Wichtl M, editor. Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis, 3rd edition. Stuttgart (D): Medpharm GmbH Scientific Publishers; 2004.

    Health Canada monograph dated 31 July 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Vegavero

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Artemisia vulgaris Extrakt (Vegavero): composition and regulation”, https://compoatlas.com/en/supplements/products/179849-artemisia-vulgaris-extrakt, updated 15 November 2026.

List recorded in 2021. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line